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Abstract 
Nanotechnology presents countless opportunities to develop new and improved consumer 
products for the benefit of the society. A most prominent nanoproduct is nanosilver. 
Nanosilver particles are generally smaller than 100 nm and contain 20–15,000 silver atoms. 
Despite the wide application of nanomaterials, there is a serious lack of information 
concerning their impact on human health. In the previous study we reported the cytotoxic of 
nanosilver on osteoblast G292 cancer cell line and the amount of IC50 determined as 3.42 
µg/ml (Moaddab et al., Iran. Nano Lett., Vol. 1, No. 1, January 2011, pp. 11-16). The purpose 
of the present study is to assess the biological assay of nanosilver on two normal cell lines of 
fibroblast (HF2), and mesenchymal stem cells. The effect of nanosilver on these cells is 
evaluated by light microscopy, and by cell proliferation and standard cytotoxicity assays. The 
results demonstrate a concentration-dependent toxicity for the cells tested, and IC50 was 
determined as 6.33, and 6.68 µg/ml in mesenchymal stem cell, and fibroblast HF2, 
respectively. There is no significant difference between the 24 h and 48 h of cells exposure to 
nanosilver.  The results show that Nano-Ag possesses low toxicity to normal cells and can 
display potential application in cancer chemoprevention and chemotherapy. 
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Introduction 
Metallic silver is subjected to new 
engineering technologies with resultant 
extraordinarily novel morphologies and 
characteristics. Instead of being made 
―big‖, metallic silver is engineered into 
ultrafine particles whose size is measured 
in nanometres (nm). When these particles 
have at least one dimension, which is less 
than 100 nm, they are named nanoparticles 
(Oberdorster et al., 2005; Warheit et al., 
2007). Nanoparticles are now used to 
target synthetic peptides, proteins, 
oligonucleotides, and plasmids to specific 
cell type while protecting these 
macromolecules from enzymatic 
degradation (Chavany et al., 1994; Janes et 
al., 2001). In addition, nanoparticles have 
been proposed for the treatment of many 
diseases that need constant drug 
concentration in the blood or drug 
targeting to specific cells or organs 
(Moghimi et al., 2001; Panyam and 
Labhasetwar, 2003; Soltani et al., 2011). 
In this respect, nanoencapsulated 
therapeutic agents such as antineoplastic 
drugs have been used with the aim of 
selectively targeting antitumor agents and 
obtaining higher drug concentration at the 
tumor site (Chawla and Amiji, 2002; 
Sahoo et al., 2004). This achievement 
appears to be important because many 
antineoplastic agents have several adverse 
side effects. Nanoparticles can be used to 
treat diseases that require a sustained 
presence of the drug at several anatomical 
sites (Panyam and Labhasetwar, 2003; Li 
et al., 2003). Use of nanosilver is 
becoming more and more widespread in 
medicine and related applications. This has 
led to an increasing number of medical 
applications of silver nanoparticles. Some 
of the products which are already available 
in the market include wound dressings, 
contraceptive devices, surgical instruments 
and bone prostheses (Cheng et al., 2004; 
Chen et al., 2006; Cohen et al., 2007; Lee 
et al., 2007; Zhang et al., 2007). 
The present study is aimed to target 
osteoblast G292, fibroblast HF2, and 
mesenchymal stem cell lines to determine 
the cytotoxic threshold of nanosilver in 
these cancerous and non cancerous cell 
lines. Moreover, in a time-course study, 
we found that the monodispersed Nano-Ag 
could keep stable at least for 12 months in 
the soluble state (data not shown). This 
stabilization of nanosilver is an important 
issue for its medical applications. 
Materials and methods 
Nanoparticle production 
The method of the present invention is to 
provide a simple preparation method for 
silver nano particles with well-controlled 
sizes in a surfactant solution. The nano 
silver colloid is prepared by the following 
steps: (1) dissolving silver nitrate crystal in 
distilled water, (2) adding surfactant, 
LABS (Linear alkyl benzene sulfonate) to 
the solution and (3) adding reducing agent 
to the solution. The method is performed 
based on undisclosed US-patent and the 
produced nanosilver is nominated as 
Nanocid
® 
(Rahman-Nya, 2009). 
Cell culture 
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The cell lines were obtained from the Cell 
Bank of Pasteur Institute of Iran. 
Fibroblast cells were seeded in flasks 
containing RPMI medium. The medium 
had contained 5-10% fetal bovine serum 
(FBS). Stem cells were cultured in DMEM 
containing low glucose. The cells were 
incubated at 37°C in a 5% CO2 
atmosphere. After 24-48 h the attached 
cells were trypsinized for 3-5 min and 
centrifuged (1,400 rpm, 5 min). The live 
cells were counted and distributed in 96 
well ELISA plate with 100 µl of culture 
medium containing 10
4
 cells in each well. 
The plate was incubated 24-48 h at 37°C 
in a 5% CO2 atmosphere to allow the cells 
to attach to the bottom of the well 
(Mosmann, 1983).  
Cell treatment with nanosilver 
Different concentrations of nanosilver 
were added to wells in duplicates.  The 
amounts of 1, 3, 5, 10, 15, 25, 50, 100 
µg/ml nanosilver were inoculated into as-
grown (1x10
4
 cells/well) and the cell 
population was then determined by optical 
microscopy at 24 and 48 hours.  
MTT assay 
Cell viability was evaluated by the MTT 
colorimetric technique (Mosmann, 1983). 
Briefly, 100 μl of the yellowish yellow 
tetrazolium MTT solution (Sigma) (3-(4, 
5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide) without 
phenol red, (5 mg/ml in PBS) was added to 
each well. The plates were incubated for 3-
4 h at 37 °C, for reduction of MTT by 
metabolically active cells, partially by 
dehydrogenase enzymes activity, to 
generate reducing equivalents such as 
NADH and NADPH. By adding MTT 
crystals the resulting intracellular purple 
formazan was solubilized and quantified 
by spectrophotometry and then the 
supernatants were removed. For 
solubilization of the MTT crystals, 100 µl 
of isopropanol or DMSO was added to 
each well. The plates were placed on a 
shaker for 15 min to complete 
solubilization of crystals and then the 
optical density of each well was 
determined. The quantity of produced 
formazan measured in the absorbance of 
545 nm, is directly proportional to the 
number of living cells in culture. Each 
experiment was done in duplicate. The 
relative cell viability (%) related to control 
wells containing cell culture medium 
without nanoparticles as a vehicle was 
calculated by [A]test/ [A]control×100. 
[A]test is the absorbance of the test sample 
and [A]control is the absorbance of the 
control sample (Mosmann, 1983). 
Statistical Analysis 
All experiments were done in duplicate, 
and the results were presented as mean ± 
standard deviation. The experimental data 
were analyzed using SPSS. Statistical 
significance was accepted at a level of p < 
0.05. To calculate IC50 values, 
concentration–response curves were 
graphed using Excel. The IC50 of the 
curves was calculated by non-linear 
regression analysis and interpolation 
according to the method of Alexander et 
al. (1999). 
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Results 
Characterization of Nanosilver 
The morphology and microstructure of 
Nano-Ag was examined by the 
transmission electron microscopy (TEM) 
method to synthesize size-controlled 
Nano-Ag. The images revealed that the 
uniform spherical nanoparticles were 
obtained. The size distribution and average 
diameter of Nano-Ag in aqueous solution 
were further characterized by LLS. The 
result was described elsewhere (Moaddab 
et al., 2011). Nano-Ag in water would 
easily   aggregate   with      particle     size  
 
distributed between 5–45 nm with an 
average diameter of 10 nm. 
Cytotoxic effects of Nano-Ag on two 
normal human cell lines 
The in vitro cytotoxic effects of Nano-Ag 
were screened against two normal human 
cell lines by means of MTT assay. As 
shown in Fig. 1, Nano-Ag showed lower 
cytotoxicity toward normal cells (M-Stem 
cell and human fibroblasts (HF2), with an 
IC50 value of 6.38 and 6.68 µg/ml, 
respectively (Fig. 2A, B). 
  
 
 
 
 
Figure 1: The percent of viability measured by MTT assay on mesenchymal stem cell and human 
fibroblast (HF2) cells after treatment with nanosilver (1.0 μg/mL to 100 μg/ml) for 24 h. The 
data are expressed as mean ± standard deviation (SD) of three independent experiments. An 
OD value of control cells (unexposed cells) was taken as 100% viability (0% cytotoxicity). 
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Figure 2: IC50 measurement of two cell lines; Cytotoxicity measured by MTT assay on (A) 
M-Stem, and (B) HF2 cells with (1.0–50µg/ml in 24 h. The data are expressed as 
mean ± standard deviation (SD) of three independent experiments. An OD value 
of control cells (Unexposed cells) was taken as 100% viability (0% cytotoxicity). 
A statistically significant difference compared to control (p < 0.05). 
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Figure 3: The percent of viability measured by MTT assay on mesenchymal stem cells. Treatment with 
nanosilver (1.0 μg/ml to 50 μg/ml) was determined after 24 and 48h. The data are expressed as 
mean ± standard deviation (SD) of three independent experiments. An OD value of control cells 
(unexposed cells) was taken as 100% viability (0% cytotoxicity). 
 
Discussion 
Nanotechnology, which deals with devices 
typically less than 100 nanometer in size, 
is expected to make a significant 
contribution to the fields of computer 
storage, semiconductors, biotechnology, 
manufacturing and energy. Nanomaterials 
can enter human tissues through several 
ports via the lungs after inhalation, through 
the digestive system and possibly through 
the skin (Jani et al., 1990; Warheit et al., 
2007). Systemic distribution of 
nanoparticles has been demonstrated after 
inhalation and oral uptake (Jani et al., 
1990; Oberdorster et al., 2002), and 
nanoparticles have been found to cross the 
blood–brain barrier, reaching the olfactory 
bulb and the cerebellum (Oberdorster et 
al., 2004). Chen and colleagues also 
reported that nanoparticles can penetrate 
the blood-testis barrier (Chen et al., 2003). 
Although organ- or cell-specific drug 
delivery through nanoparticles is a 
promising area of medicine, and 
nanoparticles might be used some day as 
sensors for intracellular mechanisms, few 
toxicology studies are available. Many of 
the artificially manufactured nanoparticles 
are made of nonbiodegradable pollutants, 
such as carbon black and metals, and the 
long-term behavior of such substances is 
unknown. Nanosilver is a liquid product 
that is being used as a potent antibacterial. 
In the previous study we showed that 
nanosilver can induce toxicity on 
osteoblastoma G292 cancerous cell line 
with a concentration-dependent toxicity 
for the cell tested (Moaddab et al., 2011).  
In the present study the effect of 
nanosilver on cell viability was estimated 
using MTT assay. The mesenchymal stem 
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cell and fibroblast HF2 were used as 
normal human cell lines. The cytotoxicity 
result showed that the IC50 of nanosilver in 
these cell lines were 6.33 and 6.68 µg/ml, 
respectively. It means that nanosilver is 
twice less toxic to normal cells compared 
with cancerous cell such as osteoblast 
G292 with IC50 of 3.42 µg/ml (Moaddab et 
al., 2011). The result obtained in this study 
is in accordance with the studies done by 
other researchers. Morphology of the C18–
4 spermatogonial stem cells after 
incubation with silver nanoparticles (SNP) 
(Ag—15 nm) at concentrations higher than 
5 µg/ml became necrotic and detached 
from the culture dishes and dramatic 
changes were induced by SNP at 
concentrations of 10 µg/ml and above.  In 
addition to necrotic areas, some cells 
retained an intact plasma membrane, 
indicating that apoptosis had occurred 
(Braydich-Stolle et al., 2005). Meanwhile, 
silver carbonate, generally considered to 
be non-hazardous, had no significant 
cytotoxic effect on mitochondrial 
functions and cell viability up to 
concentrations of 100 µg/ml. The EC50 of 
silver carbonate was calculated at 408 
µg/ml. On the other hand, silver added to 
the cells as a nanoparticulate (diameter of 
15 nm) reduced mitochondrial functions 
and cell viability drastically. The toxic 
effect of SNP started between 5 and 10 
µg/ml, with an EC50 calculated at 8.75 
µg/ml. Higher concentrations of silver 
nanoparticles could not be tested because 
of particle clumping and precipitation 
above 10 µg/ml (Braydich-Stolle et al., 
2005). Also a slight increase in LDH 
leakage was observed with silver 
nanoparticles, indicating that these 
particles interfere with cell metabolism 
rather than disrupting the plasma 
membrane. Thus, they might promote cell 
apoptosis rather than necrosis. The EC50 
of SNP was evaluated at 2.5 µg/ml 
(Braydich-Stolle et al., 2005). Upon 
exposure to silver nanoparticles for 24 h, 
morphology of primary fibroblast cells 
remained unaltered up to 25 μg/ml, 
although with a minor decrease in 
confluence. In this in vitro study, the IC50 
value for primary fibroblasts, which were 
revealed by XTT assay, was 61 μg/ml, and 
Caspase-3 activity assay indicated that the 
SNP concentrations required for the onset 
of apoptosis were found to be 3.12 μg/ml 
compared to the necrotic concentration of 
100 μg/ml. These observations were 
confirmed by confocal laser scanning 
microscopy (CLSM) studies by exposure 
of cells to ½ IC50 SNP (resulting in 
apoptosis) and 2× IC50 cells (resulting in 
necrosis) (Arora et al., 2009). The 
mechanisms by which SNP induces this 
toxicity in cancer cells are not well known. 
Our results show that normal cells possess 
much higher SNP tolerance than the 
cancerous cells, maybe due to more 
oxidative stress in cancer cells compared 
to normal cell lines which facilitate the 
possible human applications of nanosilver 
in next steps. As shown in Fig. 3, there is 
no significant difference between the 24 h 
and 48 h of mesenchymal stem cell 
exposure to nanosilver.  
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In summary, our studies show that 
silver nanoparticles exert similar toxicity 
in the fibroblast and mesenchymal stem 
cells which is nearly two times more than 
the amount needed for cancerous cells 
such as osteoblst G292 which was reported 
in the previous work (Moaddab et al., 
2011). These results suggested that Nano-
Ag possesses low toxicity to normal cells 
and can display potential application in 
cancer chemoprevention and 
chemotherapy. 
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